IP protection to support sustainable commercial development of microbiome-targeting applications. Discovering the influence of microorganisms on health, disease and wellbeing.

Microbiome targeting technology is a rapidly emerging, complex sector which improves human, animal, and crop health and well-being. Having actively advised on a full-range of IP matters involving manipulation and analysis of microbiomes for  almost two decades, HGF has one of the most experienced teams in this area throughout Europe.  

Specialising in therapeutic, diagnostic, nutraceutical, cosmetic and agricultural application, as well as related bioinformatics-powered innovations, the team is well versed in the challenges and opportunities for protecting and commercialising the whole spectrum of microbiome-related inventions, and assists the full range of microbiome-focused companies in developing robust IP strategies, including IP protection, freedom to operate, licensing, European patent opposition and litigation strategies.